🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial phase I studies how well fingolimod works in preventing chemothe...
Status
Completed
Location
Mayo Clinic
Start Date
2019-12-12
Trial ID
NCT03941743
Treatments Being Tested
The goal of this observational study is to evaluate the efficacy of fingoli...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-01
Trial ID
NCT06949956
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i....
Status
Active Not Recruiting
Location
UAB Childrens Hospital Harbor Center Neurology Dept
Start Date
2013-07-26
Trial ID
NCT01892722
Treatments Being Tested
The MRI scan is one of the most important tools for diagnosing multiple scl...
Status
Completed
Location
Zuyderland MC
Start Date
2023-09-12
Trial ID
NCT05718947
Treatments Being Tested
Demyelinating Diseases of the Central Nervous System Registry for Patients ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-06-20
Trial ID
NCT05415579
Treatments Being Tested
This study evaluates the effect of adding fish oil to Fingolimod on some se...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02939079
Treatments Being Tested
Title of Study: An Open-Label, Balanced, Randomized, 2-Treatment, 2-Sequenc...
Status
Completed
Location
Algorithme Pharma Inc.
Start Date
2015-10-29
Trial ID
NCT05145621
Treatments Being Tested
The purpose of this study is to explore the cardiac pharmacodynamics, safet...
Status
Completed
Location
Investigational site
Start Date
TBD
Trial ID
NCT02193217
Treatments Being Tested
Gilenya (fingolimod) is approved for multiple sclerosis. However, it is unc...
Status
Completed
Location
Keck School of Medicine of the University of Southern Calfornia
Start Date
2012-06
Trial ID
NCT01592097
The purpose of this study is to evaluate the change in patient-reported tre...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-05
Trial ID
NCT01317004
Treatments Being Tested